Paget-Schroetter disease surgery

Paget-Schroetter disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Paget-Schroetter disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Paget-Schroetter disease surgery On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Paget-Schroetter disease surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Paget-Schroetter disease surgery
on Paget-Schroetter disease surgery
Paget-Schroetter disease surgery in the news
Blogs on Paget-Schroetter disease surgery
Directions to Hospitals Treating Paget-Schroetter disease
Risk calculators and risk factors for Paget-Schroetter disease surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Surgery

• J. Ernesto Molina, MD, a vascular surgeon at the University of Minnesota, has expressed the following opinion:
  1. "The current acceptable treatment for that condition is lytic therapy followed by surgery. The patients were followed up to investigate the rate of recurrence. However, if surgery is not done, the problem will invariably recur. If patients are treated with only anticoagulants and even thrombolytics but no surgery, I expect the recurrence rate to be high."
  2. "Most patients who suffer this condition do not have any abnormality in their coagulation mechanism" and in fact suffer from "A direct injury to the endothelium,"
  3. "Treatment for Paget-Schroetter syndrome entails the use of thrombolytics followed by surgery to decompress the thoracic inlet and widening of the vein, usually with a vein patch."
• Some studies suggest the importance of surgical decompression, since one third of participants who did not underwent surgical decompression experienced re-thrombosis within 30 days.